Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-04

Clinical Trial Update: Effects of Atalante Exoskeleton on Gait Recovery in Non- or Poorly Ambulatory Patients With Hemiparesis in the Acute/Subacute Phase (Month 1 to 4) [NA]

View source ↗

Summary

An ongoing clinical trial evaluates whether the Atalante exoskeleton improves gait recovery in acute/subacute stroke patients with hemiparesis; the study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atalante Exoskeleton

Snippet

Sponsor: Wandercraft | Conditions: Stroke, Acute, Stroke, Ischemic | NA | Status: RECRUITING